24 Jun 2020
UK hospitals are trialling a new drug, TRV027, that aims to restore the balance between the two hormones, angiotensin II and angiotensin 1-7, to help prevent blood clots and lung damage caused by COVID-19.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024